Recombinant Human DRD1 Protein，His

Dopamine receptor D1 (DRD1) is a critical G protein-coupled receptor (GPCR) primarily involved in mediating dopaminergic signaling pathways that influence various neurological and psychiatric functions. Its role in the central nervous system has made it a focal point for research related to neurological disorders such as schizophrenia, depression, and Parkinson's disease. The reconstitution and study of DRD1 as a recombinant protein allow researchers to elucidate its structural properties, ligand-binding affinities, and downstream signaling mechanisms. Producing DRD1 in a recombinant form often involves the use of cellular expression systems, such as bacteria, yeast, or mammalian cells, enabling scientists to obtain sufficient quantities of the protein for functional assays and biophysical characterization. The study of DRD1 not only aids in understanding its normal physiological functions but also provides insights into potential therapeutic targets for the development of pharmacological agents. Furthermore, the exploration of DRD1 interactions with various compounds can pave the way for novel drug design strategies that could lead to improved treatments for dopamine-related disorders. Advances in recombinant protein technology and techniques such as cryo-electron microscopy and X-ray crystallography have been instrumental in revealing the intricate details of DRD1 structure and function, thus enriching our understanding of its pivotal role in neurotransmission and behavior.